These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32319385)

  • 1. [Clinical Characteristics and Prognosis of 56 Lymphoma Patients with Mediastinal Masses].
    Yu H; Wang L; Zhu HY; Wu W; Liang JH; Yin H; Fan L; Li JY; Xu W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):495-499. PubMed ID: 32319385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediastinal Gray Zone Lymphoma: A Wider Category Than We Think?
    Verma A; Shet T; Epari S; Gupta M; Gujral S; Khanna N; Laskar S; Sengar M; Arora B; Menon H; Banavali S
    Int J Surg Pathol; 2016 Aug; 24(5):382-93. PubMed ID: 26957476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric gray zone lymphoma according to the 2022 WHO classification: An Italian cohort study.
    Restivo GA; Farruggia P; Pillon M; Mascarin M; Elia C; Recupero S; Muggeo P; Cagnazzo C; Onofrillo D; Mura R; Furfari I; Trizzino A; Bertolini P; Sala A; De Santis R; Galimberti D; Schiavello E; Carraro E;
    Pediatr Blood Cancer; 2023 May; ():e30481. PubMed ID: 37254478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
    Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM
    Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of programmed death-1 inhibitor in the treatment of relapsed/refractory classical Hodgkin's lymphoma].
    Shan DD; Liu HM; Liu W; Huang WY; Lyu R; Deng SH; Yi SH; An G; Xu Y; Sui WW; Wang TY; Fu MW; Zhao YZ; Qiu LG; Zou DH
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):555-560. PubMed ID: 37749034
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term complete remission following tandem autologous stem cell transplantation and consolidative radiotherapy for refractory mediastinal gray-zone lymphoma.
    Takaishi K; Muto T; Mimura N; Takiguchi J; Nagao Y; Oshima-Hasegawa N; Tsukamoto S; Takeda Y; Mitsukawa S; Takeuchi M; Ohwada C; Ota S; Iseki T; Nakaseko C; Sakaida E
    Int J Hematol; 2018 Oct; 108(4):452-455. PubMed ID: 29786758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and pathological characteristics and prognosis analysis of gray zone lymphoma].
    Liu SZ; Zong XP; Cai WZ; He HJ; Ma ZX; Li JQ; Li CX; Wu DP
    Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(1):69-73. PubMed ID: 38178771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
    Pasvolsky O; Bassett RL; Ghanem S; Cuglievan B; Tewari P; Hosing C; Srour S; Ramdial J; Mahadeo KM; Khazal S; Petropoulos D; Popat U; Qazilbash M; Kebriaei P; Champlin R; Shpall EJ; Nieto Y
    BMC Cancer; 2023 Dec; 23(1):1258. PubMed ID: 38124057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal Gray Zone Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma.
    Song HN; Kim SJ; Ko YH; Kim WS
    Acta Haematol; 2016; 136(3):186-90. PubMed ID: 27623181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Programmed cell death-1 inhibitor combined with rituximab in refractory or relapsed diffuse large B-cell lymphoma: a preliminary efficacy and safety analysis].
    Qin Y; Zhao FY; Zhou Y; Jiang SY; Yang S; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1034-1039. PubMed ID: 33342160
    [No Abstract]   [Full Text] [Related]  

  • 11. [A clinical analysis of 10 cases with cardiac lymphoma].
    Li YH; Shi CY; Duan FQ; Pang Y; Li HB; Zhang LQ; Liu ZH; Ouyang L; Yue CY; Xie MC; Jiang ZJ; Xiao Y
    Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):102-106. PubMed ID: 28279032
    [No Abstract]   [Full Text] [Related]  

  • 12. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis of outcomes for primary mediastinal large B-cell lymphoma treated with RCHOP followed by radiotherapy or front-line autologous stem cell transplantation.
    Liu X; Deng T; Guo X; Guo Y; Wang L; Zhang J; Xia Z; Zhang Q; Xue K; Cao J; Shi J; Hong X
    Hematology; 2017 Jun; 22(5):258-264. PubMed ID: 27884092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.
    Yoon JH; Kim JW; Jeon YW; Lee SE; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Park CW; Cho SG
    Korean J Intern Med; 2015 May; 30(3):362-71. PubMed ID: 25995667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Efficacy of Autologous Hematopoietic Stem Cell Transplantation for Patients with Diffuse Large B-Cell Lymphoma].
    Fan D; Liu Q; Xiao F; Guo HX; Zhao H; Yan XQ; Liu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1163-1168. PubMed ID: 34362497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose Chemotherapy Combined with Autologous Hematopoietic Stem Cell Transplantation as Frontline Therapy for Intermediate/High-risk Diffuse Large B Cell Lymphoma.
    Wen Q; Gao L; Xiong JK; Li Q; Wang SB; Wang JS; Liu F; Zhang C; Liu Y; Kong PY; Peng XG; Rao J; Gao L; Zhang X
    Curr Med Sci; 2021 Jun; 41(3):465-473. PubMed ID: 34218355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of transplantation and some clinical factors on prognosis of patients with diffuse large B-cell lymphoma].
    Zhao SX; Han Y; Zhu Q; Wang Q; Zhang WJ; Chen XC; Sun AN; Jin ZM; Qiu HY; Tang XW; Fu ZZ; He GS; Miao M; Ma X; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):623-7. PubMed ID: 23815910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphoma.
    Malenda A; Kołkowska-Leśniak A; Puła B; Długosz-Danecka M; Chełstowska M; Końska A; Giza A; Lech-Marańda E; Jurczak W; Warzocha K
    Eur J Haematol; 2020 Jan; 104(1):59-66. PubMed ID: 31606909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of upfront autologous stem cell transplantation for high-intermediate/high-risk stage IV diffuse large B-cell lymphoma.
    Koviazin AK; Filatova LV; Zyuzgin IS; Artemyeva AS; Poliatskin IL; Burda DS; Volchenkov SA; Elkhova SS; Semiglazova TY
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1786. PubMed ID: 36855295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].
    Chen DB; Wang Y; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):376-81. PubMed ID: 22932404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.